178 related articles for article (PubMed ID: 38931409)
1. Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative Disorders.
Niazi SK; Magoola M; Mariam Z
Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931409
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
Volloch V; Olsen B; Rits S
Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536
[TBL] [Abstract][Full Text] [Related]
3. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
[TBL] [Abstract][Full Text] [Related]
5. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
Fatima J; Siddique YH
CNS Neurol Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38288843
[TBL] [Abstract][Full Text] [Related]
6. Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond.
Tondo G; De Marchi F; Bonardi F; Menegon F; Verrini G; Aprile D; Anselmi M; Mazzini L; Comi C
J Clin Med; 2024 May; 13(11):. PubMed ID: 38892809
[TBL] [Abstract][Full Text] [Related]
7. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.
Gnoth K; Piechotta A; Kleinschmidt M; Konrath S; Schenk M; Taudte N; Ramsbeck D; Rieckmann V; Geissler S; Eichentopf R; Barendrecht S; Hartlage-Rübsamen M; Demuth HU; Roßner S; Cynis H; Rahfeld JU; Schilling S
Alzheimers Res Ther; 2020 Nov; 12(1):149. PubMed ID: 33189132
[TBL] [Abstract][Full Text] [Related]
8. Novel drug discovery: Advancing Alzheimer's therapy through machine learning and network pharmacology.
Alshabrmi FM; Aba Alkhayl FF; Rehman A
Eur J Pharmacol; 2024 Aug; 976():176661. PubMed ID: 38795753
[TBL] [Abstract][Full Text] [Related]
9. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
Si Z; Wang X
J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of new drugs in Alzheimer's disease.
Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B
J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520
[TBL] [Abstract][Full Text] [Related]
12. The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.
Tolar M; Hey JA; Power A; Abushakra S
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473975
[TBL] [Abstract][Full Text] [Related]
13. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
[TBL] [Abstract][Full Text] [Related]
14. AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2020; 2(1):75-89. PubMed ID: 32201863
[TBL] [Abstract][Full Text] [Related]
15. Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease.
Zhang W; Smith N; Zhou Y; McGee CM; Bartoli M; Fu S; Chen J; Domena JB; Joji A; Burr H; Lv G; Cilingir EK; Bedendo S; Claure ML; Tagliaferro A; Eliezer D; Veliz EA; Zhang F; Wang C; Leblanc RM
Acta Biomater; 2024 Jun; ():. PubMed ID: 38849023
[TBL] [Abstract][Full Text] [Related]
16. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond.
Song C; Shi J; Zhang P; Zhang Y; Xu J; Zhao L; Zhang R; Wang H; Chen H
Transl Neurodegener; 2022 Mar; 11(1):18. PubMed ID: 35300725
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Disease Prevention and Treatment: Case for Optimism.
Volloch V; Olsen B; Rits S
Ann Integr Mol Med; 2020; 2(1):115-130. PubMed ID: 33043322
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]